Vault-13

Kynam Capital Management, LP

PRINCETON, NJ · CIK 1907884 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2022 · limited partnership

As an employer

$652.5m reported value -15.6% vs Q1 2023
23positions
84.1%in top 10
0 new 10 added 6 reduced 11 sold out vs Q1 2023

Options: 2 call positions ($2.7m notional), 1 put positions ($71.8m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 2,900,000 $141.1m21.63% 21.63% ReducedShares held: Q3 2022 2.0m, Q4 2022 2.6m, Q1 2023 2.9m, Q2 2023 2.9m -18.2k -18,237 -0.6%
2 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 2,600,000 $88.2m13.52% 13.52% AddedShares held: Q3 2022 1.6m, Q4 2022 1.6m, Q1 2023 1.4m, Q2 2023 2.6m +1.2m +1,190,549 84.5%
3 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,262,004 $68.3m10.46% 10.46% AddedShares held: Q3 2022 2.3m, Q4 2022 2.6m, Q1 2023 3.2m, Q2 2023 3.3m +56.0k +56,018 1.8%
4 VAXCYTE INC COM PCVX PCVX 1,300,000 $64.9m9.95% 9.95% AddedShares held: Q3 2022 698.6k, Q4 2022 703.4k, Q1 2023 1.2m, Q2 2023 1.3m +83.2k +83,216 6.8%
5 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 4,890,706 $49.5m7.59% 7.59% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.7m, Q2 2023 4.9m +1.2m +1,151,734 30.8%
6 VERA THERAPEUTICS INC CL A VERA VERA 3,000,000 $48.1m7.38% 7.38% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m, Q1 2023 3.4m, Q2 2023 3.0m -372.4k -372,428 -11.0%
7 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 975,298 $26.9m4.13% 4.13% ReducedShares held: Q3 2022 519.2k, Q4 2022 520.9k, Q1 2023 1.4m, Q2 2023 975.3k -399.7k -399,702 -29.1%
8 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,454,730 $22.3m3.42% 3.42% ReducedShares held: Q3 2022 416.7k, Q4 2022 418.1k, Q1 2023 1.6m, Q2 2023 1.5m -108.9k -108,865 -7.0%
9 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 2,848,197 $20.1m3.07% 3.07% AddedShares held: Q3 2022 435.1k, Q4 2022 0, Q1 2023 1.0m, Q2 2023 2.8m +1.8m +1,848,197 184.8%
10 COGENT BIOSCIENCES INC COM COGT COGT 1,617,391 $19.1m2.93% 2.93% AddedShares held: Q3 2022 985.2k, Q4 2022 794.0k, Q1 2023 400.0k, Q2 2023 1.6m +1.2m +1,217,417 304.4%
11 BURNING ROCK BIOTECH LTD SPONSORED ADS SPONSORED ADS 8,500,000 $18.3m2.81% 2.81% AddedShares held: Q3 2022 6.7m, Q4 2022 7.4m, Q1 2023 8.0m, Q2 2023 8.5m +479.4k +479,375 6.0%
12 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 709,498 $16.9m2.59% 2.59% AddedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 543.6k, Q2 2023 709.5k +165.9k +165,895 30.5%
13 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 3,924,602 $14.3m2.19% 2.19% AddedShares held: Q3 2022 1.4m, Q4 2022 1.2m, Q1 2023 3.8m, Q2 2023 3.9m +116.7k +116,726 3.1%
14 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 12,000,000 $14.3m2.19% 2.19% UnchangedShares held: Q3 2022 6.7m, Q4 2022 9.6m, Q1 2023 12.0m, Q2 2023 12.0m
15 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,642,244 $12.9m1.98% 1.98% UnchangedShares held: Q3 2022 1.7m, Q4 2022 1.8m, Q1 2023 1.6m, Q2 2023 1.6m
16 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 1,304,332 $11.8m1.81% 1.81% ReducedShares held: Q3 2022 1.4m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 1.3m -707.5k -707,521 -35.2%
17 SUTRO BIOPHARMA INC COM COM 1,500,000 $7.0m1.07% 1.07% AddedShares held: Q3 2022 0, Q4 2022 404.5k, Q1 2023 901.8k, Q2 2023 1.5m +598.2k +598,164 66.3%
18 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 729,077 $4.5m0.69% 0.69% UnchangedShares held: Q3 2022 731.5k, Q4 2022 733.9k, Q1 2023 729.1k, Q2 2023 729.1k
19 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 473,070 $1.7m0.26% 0.26% UnchangedShares held: Q3 2022 559.8k, Q4 2022 561.6k, Q1 2023 473.1k, Q2 2023 473.1k
20 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 92,602 $1.5m0.23% 0.23% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 92.6k, Q2 2023 92.6k
21 CONNECT BIOPHARMA HLDGS LTD ADS ADS 535,005 $602.6k0.09% 0.09% ReducedShares held: Q3 2022 739.6k, Q4 2022 739.6k, Q1 2023 739.6k, Q2 2023 535.0k -204.6k -204,644 -27.7%
22 NEOLEUKIN THERAPEUTICS INC COM COM 119,966 $99.6k0.02% 0.02% UnchangedShares held: Q3 2022 120.4k, Q4 2022 120.8k, Q1 2023 120.0k, Q2 2023 120.0k
23 CATALYST BIOSCIENCES INC COM NEW COM NEW 89,886 $31.6k0.00% 0.00% UnchangedShares held: Q3 2022 90.2k, Q4 2022 90.5k, Q1 2023 89.9k, Q2 2023 89.9k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
HORIZON THERAPEUTICS PUB L HZNP HZNP 1,094,620 $119.5m1.1m shares
SEAGEN INC SGEN SGEN 100,000 $20.2m100.0k shares
MIRATI THERAPEUTICS INC MRTX MRTX 499,853 $18.6m499.9k shares
GSK PLC GSK GSK 498,329 $17.7m498.3k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 1,800,000 $11.0m1.8m shares
ALLOGENE THERAPEUTICS INC ALLO ALLO 1,495,981 $7.4m1.5m shares
SERES THERAPEUTICS INC 768,913 $4.4m768.9k shares
GOSSAMER BIO INC GOSS GOSS 1,502,866 $1.9m1.5m shares
XENON PHARMACEUTICALS INC XENE XENE 28,696 $1.0m28.7k shares
ARCELLX INC ACLX ACLX 31,336 $965.5k31.3k shares
MERUS N V MRUS MRUS 21,457 $394.8k21.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ARGENX SE ARGX · Put ARGXPut 184,300 $71.8m184.3k shares Added
FIBROGEN INC Call Call 586,500 $1.6m586.5k shares New
PTC THERAPEUTICS INC PTCT · Call PTCTCall 28,500 $1.2m28.5k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
BURNING ROCK BIOTECH LTD 13G · filed 2026-05-15 14.0% +3.0 pts 13G 2026-05-15
SYNDAX PHARMACEUTICALS INC SNDX · 13G · filed 2025-02-14 SNDX 10.0%≈ $186.2m 13G 2025-02-14
CYTOMX THERAPEUTICS INC CTMX · 13G · filed 2026-08-14 CTMX 10.0% +3.1 pts 13G 2026-08-14
CELLDEX THERAPEUTICS INC NEW CLDX · 13G · filed 2026-08-14 CLDX 6.8% -2.0 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 5.7% +4.2 pts 13G 2026-08-14
SUTRO BIOPHARMA INC 13G · filed 2026-05-15 5.3% -1.2 pts 13G 2026-05-15
CULLINAN THERAPEUTICS INC CGEM · 13G · filed 2026-03-04 CGEM 5.3%≈ $56.7m new 13G 2026-03-04